Concepedia

Author

Iris Faull

Guardant (United States)ORCID

Also Known As

Faull, Iris, I. Faull, Iris Faull

66

Publications

668

Citations

11

H-Index

9

Concepts

All Affiliations

Guardant (United States)Hospital Del MarUniversitat Autònoma de BarcelonaCentro de Investigación Biomédica en Red de CáncerHospital Clínico Universitario Virgen de la Victoria
IF

About

Iris Faull is an author at Guardant (United States) specializing in lung cancer, molecular diagnostics, and sequencing.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

25

2

Medicine

1

1

25

3

Pathology

1

1

25

4

Lung Cancer

1

1

25

5

Molecular Diagnostics

1

1

25

Iris Faull

×

11

Publications

605

Citations

10

H-Index

YearCitations

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Joan Albanell, Antonio González, Manuel Ruíz‐Borrego,

Annals of Oncology

2011

120

Genomic profile of advanced breast cancer in circulating tumour DNA

Belinda Kingston, Rosalind Cutts, Hannah Bye,

Nature Communications

2021

94

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Joana Vidal, David Casadevall, Beatríz Bellosillo,

Clinical Cancer Research

2021

89

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Trever G. Bivona,

Cancers

2019

68

Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non–Small-Cell Lung Cancer

Ramón Palmero, Álvaro Taus, Santiago Viteri,

JCO Precision Oncology

2021

62

High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer

Xavier Bessa, Joana Vidal, Joan Carles Balboa,

Annals of Oncology

2023

44

Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients

Wanyuan Cui, Charlotte Milner-Watts, Hazel O’Sullivan,

European Journal of Cancer

2022

37

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

Olga Martínez‐Sáez, Tomás Pascual, Fara Brasó‐Maristany,

npj Breast Cancer

2021

36

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Jon Zugazagoitia, Ana Gómez‐Rueda, Eloísa Jantus‐Lewintre,

Lung Cancer

2019

25

Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer

Manuel Benavides, Julia Alcaide, Esperanza Torres,

ESMO Open

2022

20

Page 1